Tabid, Dan Aiza .

HRN: 20-46-76  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/12/2023
10/18/2023
IVT
300mg
Q6hrs
URTI; BFC
Waiting Final Action 
10/15/2023
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
10/15/2023
10/19/2023
PO
2.5ml
OD
PCAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: